RE:TLT scratching the surfacedatawork wrote: Given the significance that this technology represents. I can easily see the SP rocketing to at least $125-$200 once things are in full swing. Based of course on the FDA approval and Phase II success. IMO it also explains why there has been no jv to date. TLT knows what they are sitting on and the vc's are ruthless at this stage of the game. The foundation is being laid to treat countless cancers. I also feel there is immense potential to tie PET/CT scans and TLT's technology together in the future with some form of Electromagnetic energy. I honestly feel that TLT has only just begun to scratch he surface of the full potential of this technology. I may be a painfully slow wait currently. But I fell that we will all be handsomely rewarded for our investment in this ground breaking CURE. As the saying goes "Good things come to those who wait." just my $0.02
Due respect but that's a 2014-2019 statement.....
Please in the future.. list the Big Pharma. and their pipeline to see why perhaps we were lowballed
Merck, Novartis, Roche and Sanofi all have pipelines for the indications our technology covers till 2022.
That's why I suggested Medtronic.. a medical device company for lung cancer ..
Deals can be adjusted as ive shown with Immunomedics... you get a 'base deal' and incentives to dramatically increase value.. or do it on percentage of growth.. there are tons of ways to split the cap of a 'market'
if we cant get past the 'future' and the 'imagine' talk on this forum without serious discourse on pharmas pipelines and direction in 2020.. then this board is garbage..
it's been a fun 5 years ... some here are legit, some arent.. but im done.. the science is proved up enough.. and validated through photofrin 25 years..... globally the technology is moving really quickly..
time to JV up and get into China
I expect Roger to have a plan at the AGM and he will be grilled on it if he pulls the too early and independent card... that is utter garbage talk